Rebamipide (nanoparticulated)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rebamipide (nanoparticulated), covering 2023-09-21 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients [Phase 3]